Clinical Trial Update: A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

View source ↗

Summary

A completed clinical trial update from Ipsen studying participants’ experiences with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and acromegaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Gastroenteropancreatic Neuroendocrine Tumor

Snippet

Sponsor: Ipsen | Conditions: Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly | Status: COMPLETED